Verano Holdings Corp (VRNOF)
4.19
-0.06
(-1.41%)
USD |
OTCM |
May 31, 16:00
Verano Holdings Enterprise Value: 1.693B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 1.693B |
| May 30, 2024 | 1.714B |
| May 29, 2024 | 1.593B |
| May 28, 2024 | 1.621B |
| May 24, 2024 | 1.669B |
| May 23, 2024 | 1.696B |
| May 22, 2024 | 1.879B |
| May 21, 2024 | 1.961B |
| May 20, 2024 | 1.927B |
| May 17, 2024 | 2.041B |
| May 16, 2024 | 2.078B |
| May 15, 2024 | 2.109B |
| May 14, 2024 | 2.178B |
| May 13, 2024 | 1.944B |
| May 10, 2024 | 1.968B |
| May 09, 2024 | 1.992B |
| May 08, 2024 | 1.937B |
| May 07, 2024 | 1.954B |
| May 06, 2024 | 2.037B |
| May 03, 2024 | 2.023B |
| May 02, 2024 | 2.054B |
| May 01, 2024 | 1.982B |
| April 30, 2024 | 2.412B |
| April 29, 2024 | 1.989B |
| April 26, 2024 | 1.948B |
| Date | Value |
|---|---|
| April 25, 2024 | 1.868B |
| April 24, 2024 | 2.041B |
| April 23, 2024 | 1.913B |
| April 22, 2024 | 1.903B |
| April 19, 2024 | 1.961B |
| April 18, 2024 | 2.092B |
| April 17, 2024 | 2.109B |
| April 16, 2024 | 1.937B |
| April 15, 2024 | 1.961B |
| April 12, 2024 | 1.996B |
| April 11, 2024 | 2.120B |
| April 10, 2024 | 2.144B |
| April 09, 2024 | 2.295B |
| April 08, 2024 | 2.316B |
| April 05, 2024 | 2.271B |
| April 04, 2024 | 2.189B |
| April 03, 2024 | 2.350B |
| April 02, 2024 | 2.350B |
| April 01, 2024 | 2.419B |
| March 31, 2024 | 2.295B |
| March 28, 2024 | 2.315B |
| March 27, 2024 | 2.425B |
| March 26, 2024 | 2.153B |
| March 25, 2024 | 2.119B |
| March 22, 2024 | 2.284B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.211B
Minimum
Jul 27 2023
7.352B
Maximum
Feb 19 2021
2.184B
Average
2.035B
Median
Sep 18 2023
Enterprise Value Benchmarks
| Tilray Brands Inc | 1.648B |
| Flora Growth Corp | 13.89M |
| Perspective Therapeutics Inc | 680.29M |
| Electromed Inc | 114.83M |
| Xtant Medical Holdings Inc | 116.30M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.822M |
| Revenue (Quarterly) | 221.31M |
| Total Expenses (Quarterly) | 198.64M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 51.04% |
| Profit Margin (Quarterly) | -2.18% |
| Earnings Yield | -7.42% |
| Operating Earnings Yield | 9.17% |
| Normalized Earnings Yield | -4.940 |